Neural Regeneration Research ›› 2017, Vol. 12 ›› Issue (4): 534-537.doi: 10.4103/1673-5374.205082

Previous Articles     Next Articles

Phosphatidylserine improves axonal transport by inhibition of HDAC and has potential in treatment of neurodegenerative diseases

Shiran Naftelberg1, Gil Ast1, Eran Perlson2   

  1. 1 Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; 2 Department of Physiology and Pharmacology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
  • Received:2017-03-20 Online:2017-04-15 Published:2017-04-15
  • Contact: Gil Ast, Ph.D. or Eran Perlson, Ph.D., gilast@post.tau.ac.il or eranpe@post.tau.ac.il.
  • Supported by:

    Funding for this work was provided by grants from the Dysautonomia Foundation. Israel Science Foundation (ISF) [142/13, 1439/14], and by Teva Pharmaceutical Industries Ltd as part of the Israeli National Network of Excellence in Neuroscience (NNE) [1234944]. E.P. was supported by grants from the Israel Science Foundation (ISF) [561/11]; and the European Research Council (ERC) [309377]. S.N. was supported by grants from Teva Pharmaceutical Industries Ltd. under the Israeli National Network of Excellence in Neuroscience.

Abstract:

Familial dysautonomia (FD) is a rare children neurodegenerative disease caused due to a point mutation in the IKBKAP gene that results in decreased IKK complex-associated protein (IKAP) protein production. The disease affects mostly the dorsal root ganglion (DRG) and the sympathetic ganglion. Recently, we found that the molecular mechanisms underlying neurodegeneration in FD patients are defects in axonal transport of nerve growth factors and microtubule stability in the DRG. Neurons are highly polarized cells with very long axons. In order to survive and maintain proper function, neurons depend on transport of proteins and other cellular components from the neuronal body along the axons. We further demonstrated that IKAP is necessary for axon maintenance and showed that phosphatidylserine acts as an HDAC6 inhibitor to rescue neuronal function in FD cells. In this review, we will highlight our latest research findings.

Key words: axonal transport, neurodegeneration, microtubule, familial dysautonomia, phosphatidylserine, HDAC6